Biora Therapeutics Progresses its BioJet™ Systemic Oral Delivery Platform
September 05, 2023 08:00 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced achievement of its device...
Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
August 14, 2023 16:01 ET
|
Biora Therapeutics, Inc.
NaviCap™ targeted oral delivery platform on track for September IND filing; achieved successful device function study results in humans with phase 1-ready device BioJet™ systemic oral delivery...
Biora Therapeutics Announces New Patents Covering its BioJet™ Systemic Oral Delivery Platform
August 03, 2023 08:00 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced the issuance of a new patent and...
Biora Therapeutics to Participate in Canaccord Genuity 43rd Annual Growth Conference
August 02, 2023 08:00 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that management will be attending...
Biora Therapeutics Announces Clinical Device Performance Study Results for its NaviCap™ Targeted Oral Delivery Platform
July 27, 2023 08:00 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, July 27, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced progress with its latest clinical...
Biora Therapeutics to Report Second Quarter 2023 Financial Results and Provide Corporate Update
July 17, 2023 06:00 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, July 17, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it will report financial...
Biora Therapeutics Continues to Monetize Legacy Diagnostics Assets
July 05, 2023 08:00 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, July 05, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it has completed an agreement...
Biora Therapeutics Announces New Patents for its NaviCap™ Targeted Oral Delivery Platform
June 28, 2023 08:30 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, June 28, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it has been awarded a group...
Biora Therapeutics Presents Data on the BioJet™ Systemic Oral Delivery Platform at the American Diabetes Association 83rd Scientific Sessions
June 26, 2023 06:00 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, June 26, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today shared detailed results from its preclinical...
Biora Therapeutics Announces Closing of $8 Million Registered Direct Offering of Common Stock and Warrants Priced At-the-Market Under Nasdaq Rules
June 14, 2023 16:05 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, June 14, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery (“Biora” or the “Company”), today announced the...